HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michiyasu Suzuki Selected Research

sphingosine phosphorylcholine

5/2015A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts.
2/2014A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study.
8/2009Elevated concentrations of sphingosylphosphorylcholine in cerebrospinal fluid after subarachnoid hemorrhage: a possible role as a spasmogen.
1/2008Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michiyasu Suzuki Research Topics

Disease

16Neoplasms (Cancer)
10/2018 - 01/2002
9Traumatic Brain Injuries (Traumatic Brain Injury)
02/2019 - 02/2002
9Hematoma
11/2017 - 01/2005
9Hypothermia
01/2017 - 11/2003
8Brain Ischemia (Cerebral Ischemia)
10/2021 - 03/2002
7Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
10/2021 - 01/2008
7Ischemia
12/2018 - 09/2002
7Glioma (Gliomas)
08/2017 - 01/2002
6Ischemic Stroke
12/2021 - 04/2007
6Hemorrhage
04/2021 - 07/2006
6Epilepsy (Aura)
01/2021 - 08/2015
6Intracranial Vasospasm
04/2016 - 07/2002
5Seizures (Absence Seizure)
09/2017 - 02/2004
3Drug Resistant Epilepsy
01/2021 - 02/2008
3Hypertension (High Blood Pressure)
03/2020 - 04/2016
3Intracranial Aneurysm (Cerebral Aneurysm)
03/2020 - 04/2010
3Stroke (Strokes)
10/2019 - 01/2011
3Cerebral Infarction
10/2018 - 02/2013
3Infarction (Infarctions)
10/2018 - 09/2009
3Glioblastoma (Glioblastoma Multiforme)
08/2017 - 10/2002
3Pathologic Constriction (Stenosis)
05/2016 - 04/2005
3Aneurysm (Aneurysms)
12/2014 - 04/2011
3Brain Neoplasms (Brain Tumor)
06/2011 - 04/2007
2Atrial Fibrillation
06/2020 - 11/2014
2Wounds and Injuries (Trauma)
06/2020 - 01/2013
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2018 - 09/2009
2Necrosis
08/2015 - 01/2014
2Thrombosis (Thrombus)
01/2014 - 04/2010
2Brain Injuries (Brain Injury)
01/2014 - 01/2011
2Hypoxia (Hypoxemia)
01/2013 - 02/2007
2Cysts
01/2009 - 10/2002
2Cerebral Hemorrhage
01/2006 - 01/2005
1Transient Ischemic Attack
12/2021
1Acute Subdural Hematoma
04/2021
1Carotid Stenosis (Carotid Artery Stenosis)
06/2020
1Intracranial Embolism
05/2020
1Traumatic Intracranial Hemorrhage
07/2019
1Thrombophilia
10/2018
1Adenomyosis
10/2018
1Embolic Stroke
10/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018
1Brain Concussion (Cerebral Concussion)
12/2017

Drug/Important Bio-Agent (IBA)

7Tissue Plasminogen Activator (Alteplase)FDA Link
12/2021 - 04/2007
6Glutamic Acid (Glutamate)FDA Link
01/2017 - 02/2002
5Penicillin G (Benzylpenicillin)FDA LinkGeneric
11/2019 - 03/2012
4sphingosine phosphorylcholineIBA
05/2015 - 01/2008
4rho-Associated KinasesIBA
05/2015 - 07/2002
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014 - 09/2002
3Cilostazol (Pletal)FDA LinkGeneric
10/2021 - 02/2007
3Acetazolamide (Diamox)FDA LinkGeneric
06/2020 - 05/2004
3fibrin fragment D (D-dimer)IBA
02/2019 - 01/2009
3Messenger RNA (mRNA)IBA
08/2010 - 10/2002
3Proteins (Proteins, Gene)FDA Link
12/2009 - 07/2006
2Pharmaceutical PreparationsIBA
01/2021 - 10/2017
2idarucizumabIBA
06/2020 - 06/2020
2CholesterolIBA
03/2020 - 05/2015
2Indicators and Reagents (Reagents)IBA
10/2019 - 01/2011
2Biomarkers (Surrogate Marker)IBA
02/2019 - 12/2017
2MucinsIBA
10/2018 - 07/2014
2RivaroxabanIBA
10/2018 - 11/2014
2LipidsIBA
01/2016 - 09/2009
2Biological ProductsIBA
01/2016 - 01/2002
2Therapeutic UsesIBA
03/2015 - 03/2012
2GABA-A Receptors (GABA(A) Receptor)IBA
07/2014 - 10/2010
2Eicosapentaenoic AcidIBA
02/2014 - 01/2008
2CytokinesIBA
01/2014 - 12/2009
2Neuroprotective AgentsIBA
02/2013 - 01/2011
2iomazenilIBA
01/2013 - 10/2010
2Adrenocorticotropic Hormone (ACTH)FDA Link
01/2010 - 02/2004
2Interleukin-6 (Interleukin 6)IBA
12/2009 - 12/2004
2DNA (Deoxyribonucleic Acid)IBA
09/2009 - 01/2002
2Coloring Agents (Dyes)IBA
01/2004 - 10/2003
1DabigatranFDA Link
06/2020
1AnticoagulantsIBA
06/2020
1Thromboplastin (Tissue Factor)IBA
02/2019
1Immunoglobulin G (IgG)IBA
10/2018
1CalciumIBA
04/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1IfosfamideFDA LinkGeneric
01/2018
1TitaniumIBA
09/2017
1Carmustine (FIVB)FDA Link
08/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2017

Therapy/Procedure

24Therapeutics
12/2021 - 02/2004
6Craniotomy
04/2021 - 02/2004
4Radiotherapy
01/2018 - 11/2002
4Induced Hypothermia
03/2015 - 01/2014
3Thrombectomy
05/2020 - 04/2010
3Drug Therapy (Chemotherapy)
01/2018 - 11/2002
3Conservative Treatment
11/2017 - 01/2006
3Surgical Instruments (Clip)
06/2016 - 04/2011
2Anesthesia
01/2021 - 08/2013
2Cryosurgery
01/2018 - 08/2015
2Rewarming
01/2016 - 01/2014
2Thrombolytic Therapy
09/2009 - 04/2007
1Blood Transfusion (Blood Transfusions)
04/2021
1Transcatheter Aortic Valve Replacement
05/2020
1Cannula
09/2017
1Hemodilution
04/2016
1Laminectomy
01/2016